Boutten Anne, Goven Delphine, Artaud-Macari Elise, Bonay Marcel
Université Paris 7, Faculté de médecine Denis Diderot-site Bichat, Paris, France.
Med Sci (Paris). 2011 Nov;27(11):966-72. doi: 10.1051/medsci/20112711012. Epub 2011 Nov 30.
Airways are continually exposed to multiple inhaled oxidants and protect themselves with cellular and extracellular antioxidants throughout the epithelial lining fluid and tissues. Oxidative stress, resulting from the increased oxidative burden and decreased level of antioxidant proteins, is involved in cellular and tissue damage related to the pathogenesis of many acute and chronic respiratory diseases. Evidence suggested that nuclear factor erythroid-2-related factor 2 (Nrf2), a transcription factor that controls antioxidant response element (ARE)-regulated antioxidant and cytoprotective genes has an essential protective role in the lungs against oxidative airway diseases. Therefore, Nrf2 promises to be an attractive therapeutic target for intervention and prevention strategies in respiratory diseases. We have reviewed major findings on the mechanisms of lung protection against oxidative stress by Nrf2 and the current literature suggesting that Nrf2 is a valuable therapeutic target.
气道持续暴露于多种吸入性氧化剂中,并通过整个上皮衬液和组织中的细胞内和细胞外抗氧化剂来保护自身。氧化应激是由氧化负担增加和抗氧化蛋白水平降低引起的,它与许多急性和慢性呼吸道疾病发病机制相关的细胞和组织损伤有关。有证据表明,核因子红细胞2相关因子2(Nrf2)是一种控制抗氧化反应元件(ARE)调节的抗氧化和细胞保护基因的转录因子,在肺部对抗氧化性气道疾病中具有重要的保护作用。因此,Nrf2有望成为呼吸系统疾病干预和预防策略中一个有吸引力的治疗靶点。我们回顾了关于Nrf2对肺部氧化应激保护机制的主要研究结果以及当前文献,这些研究表明Nrf2是一个有价值的治疗靶点。